Inhibitors of phospholipid synthesis and methods of use
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsArvin Gouw, Steven R. Schow, Robert J. Greenhouse, Toni Kline, Dean W. Felsher
Life of this patent
Estimating the term…
Abstract
Inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT) are provided; and methods of use in the treatment of cancer; and treatment of conditions relating to metabolic syndrome, hyperlipidemia, infection and inflammation.
Claims45
A GPAT inhibitor of the formula (I):
- wherein:
- R′ and R′″ are each independently selected from alkyl, substituted alkyl, alkyl alkenyl, alkyl alkynyl, cycloalkyl, cycloalkyl(alkyl), heterocycloalkyl, heterocycloalkyl(alkyl), substituted heterocycloalkyl, aryl, substituted aryl, aryl(alkyl), substituted aryl(alkyl), heteroaryl, substituted heteroaryl, and halo(alkyl);
- Z′ and Z′″ are optional substituents selected from alkynyl, hydroxy, alkyl(hydroxy), ester, ether, nitrile/cyano, trifluoromethyl, trifluoromethyl ether, trifluoromethyl thioether, trifluoromethyl sulfoxide, trifluoromethyl sulfone, halide, polyalcohol, a straight chain or cyclic saccharide, amine, polyamine, ammonium, amide, azido, nitro, isonitrile, sulfate/sulfonic acid, sulfonate, sulfinate, sulfoxide, sulfone, carboxylate, carboxyl ester, ketone, aldehyde, carboxyl amide, lactone, amidine, sulfonamide, phosphate, phosphonate, phosphinate, boronic acid, boronate ester, amide, thiolate/thiol, thioester, and a carboxy isostere, wherein Z′ or Z′″ optionally forms a bond to a second compound of formula (I);
- R″ is selected from hydrogen, alkyl, substituted alkyl, OR1a, NR1a2 and SR1a;
- R1a is selected H, COR2a, SO2R2a, NHR2a, and NHCOR2a, wherein each R2a are independently selected from alkyl, substituted alkyl, alkyl alkenyl, alkyl alkynyl, cycloalkyl, cycloalkyl(alkyl), heterocycloalkyl, heterocycloalkyl(alkyl), substituted heterocycloalkyl, aryl, substituted aryl, aryl(alkyl), substituted aryl(alkyl), heteroaryl, substituted heteroaryl, and halo(alkyl);
- or R″ and Z′ or Z′″ together with the atoms to which they are attached form a cyclic group selected from heterocycloalkyl, or substituted heterocycloalkyl;
- and
- X1 is selected from sulfonyl, sulfinyl, sulfonimidoyl, phosphonyl, phosphinate, thiophosphonyl, thiophosphinate, and phosphonamidate,
- or a pharmaceutically acceptable salt or solvate thereof.
The GPAT inhibitor of any one of the preceding claims wherein, X′ is —SO2—, and Z′″ is —CO2Ra, and at least one of Y1-Y4 is N.
The GPAT inhibitor of any one of the preceding claims, wherein the compound includes one or more chiral centers, and wherein each chiral center is independently of R-configuration, S-configuration or a mixture thereof.
Dependencies are inferred from the claim text.